^
Association details:
| Biomarker: | PD-L1 expression |
|---|---|
| Cancer: | Gastric Adenocarcinoma |
| Drug Class: | PD-L1 inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Title:
613 - Molecular classification of gastric adenocarcinoma guides immunotherapy in a Chinese cohort
Published date:
03/10/2021
Excerpt:
Tumor samples from 734 gastric adenocarcinoma patients were analyzed by next-generation sequencing...Six EBV positive patients with concurrent PD-L1 CPS > 5 acquired more favorable benefit from anti-PD-1/PD-L1 therapy with an objective response rate of 50.0%.
